5省市二线抗结核药品供应保障现状调研及政策建议

通过对中国5个省市地区二线抗结核药品的供应保障情况进行调研,对关键知情人进行焦点小组访谈,分析供应保障问题,为相关政策制定提供参考。调研发现,我国三级结核病防治网络建设基本完善,各地耐药患者疗程用药方案基本配齐。部分药品存在采购价格过低、采购量不足、供应效率低等问题。相关方存在缺乏国家层级政策统筹、医保实际报销水平较低、结核科边缘化等执行困难。建议针对性开展国家集中采购和定点生产;加速抗结核新药研发、引进;鼓励仿制药研发、上市,完善相关保障制度和监管体系,使更多耐药结核患者受益。

Research on the Supply Situation of the Second-line Anti-Tuberculosis Drugs in 5 Provinces&Cities and Policy Suggestion

This paper investigates the supply of second-line anti-tuberculosis drugs in 5 provinces and cities in China,conducts focus group interviews with key informants,analyzes supply issues,and provides reference for relevant policy formulation.The investigation finds that China has built perfect the 3-level tuberculosis control network,and the medication regimen for drug-resistant patients in various regions is basically complete.Some drugs have several problems such as low purchasing price,insufficient purchasing quantity,inefficient supply etc.Some implementation difficulties are as follows:lack of top-level design,insufficient actual reimbursement of medical insurance and marginalization of tuberculosis department.It is suggested that government should carry out centralized procurement and designated production,accelerating the R&G and importation of innovative anti-tuberculosis drugs,encouraging the R&G and listing of generic drugs,and improving the security and regulatory system,so as to benefit more drug-resistant tuberculosis patients.